PMID- 35858014 OWN - NLM STAT- MEDLINE DCOM- 20221111 LR - 20221207 IS - 1806-9460 (Electronic) IS - 1516-3180 (Print) IS - 1516-3180 (Linking) VI - 140 IP - 6 DP - 2022 Nov-Dec TI - Association between glycemic control and albuminuria among Peruvian adults with diabetes mellitus 2: a cross-sectional analytical study. PG - 767-774 LID - 10.1590/1516-3180.2021.0448.R2.07022022 [doi] AB - BACKGROUND: Albuminuria is a risk factor for microvascular and macrovascular complications in the diabetic population. However, few studies have correlated poor glycemic control and albuminuria prevalence in Hispanic populations. OBJECTIVE: To evaluate the association between glycemic control and albuminuria among Peruvian adults with type 2 diabetes mellitus (T2DM). DESIGN AND SETTING: Cross-sectional analytical study among adults with T2DM in Lima, Peru. METHODS: We included adults over 18 years old who were in a clinical follow-up program at a private clinic in Lima in 2018. Poor glycemic control was defined as a serum value of glycosylated hemoglobin A1C (HbA1C) >/= 7%. Albuminuria was defined as albumin values > 30 mg/dl in the first morning urine. We generated generalized linear regression models from the Poisson family with robust variance. We calculated the crude and adjusted prevalence ratios (PRs) with their 95% confidence interval (CI). RESULTS: We analyzed 907 participants of median age 58 years (interquartile range, IQR 49 to 66), and 62.8% were males. The prevalence of poor glycemic control was 39.8%, and the prevalence of albuminuria was 22.7%. The prevalences of albuminuria in groups with poor glycemic control and adequate glycemic control were 32.7% and 16.1%, respectively. In the adjusted regression analysis, we found a statistically significant association between poor glycemic control and albuminuria (annual percentage rate, aPR = 1.70; 95% CI: 1.28-2.27). CONCLUSIONS: The prevalence of poor glycemic control and albuminuria was high in our study population. Moreover, Peruvian T2DM adults with poor glycemic control were more likely to have albuminuria. FAU - Collazos-Huaman, Lucero Del Carmen AU - Collazos-Huaman LDC AUID- ORCID: 0000-0002-9314-1181 AD - Undergraduate Student, Faculty of Medicine, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru. FAU - Guerreros-Espino, Camila AU - Guerreros-Espino C AUID- ORCID: 0000-0002-3170-2254 AD - Undergraduate Student, Faculty of Medicine, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru. FAU - Herrera-Anazco, Percy AU - Herrera-Anazco P AUID- ORCID: 0000-0003-0282-6634 AD - MD, MHEd. Researcher, Universidad Privada San Juan Bautista (UPSJB), Lima, Peru; and Assistant Manager, EsSalud, Instituto de Evaluacion de Tecnologias en Salud e Investigacion, Lima, Peru. FAU - Benites-Zapata, Vicente Aleixandre AU - Benites-Zapata VA AUID- ORCID: 0000-0002-9158-1108 AD - MD. Researcher, Unidad para la Generacion y Sintesis de Evidencias en Salud, Universidad San Ignacio de Loyola (USIL), Lima, Peru. LA - eng PT - Journal Article PL - Brazil TA - Sao Paulo Med J JT - Sao Paulo medical journal = Revista paulista de medicina JID - 100897261 RN - 0 (Glycated Hemoglobin A) RN - 0 (Blood Glucose) SB - IM MH - Adult MH - Male MH - Humans MH - Middle Aged MH - Adolescent MH - Female MH - *Albuminuria/complications/epidemiology MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Peru/epidemiology MH - Glycemic Control MH - Cross-Sectional Studies MH - Glycated Hemoglobin/analysis MH - Blood Glucose PMC - PMC9671563 COIS- Conflict of interest: The authors declare that they did not have any conflicts of interest EDAT- 2022/07/21 06:00 MHDA- 2022/11/15 06:00 PMCR- 2022/07/15 CRDT- 2022/07/20 15:14 PHST- 2021/05/25 00:00 [received] PHST- 2022/02/07 00:00 [accepted] PHST- 2022/07/21 06:00 [pubmed] PHST- 2022/11/15 06:00 [medline] PHST- 2022/07/20 15:14 [entrez] PHST- 2022/07/15 00:00 [pmc-release] AID - S1516-31802022005017201 [pii] AID - 10.1590/1516-3180.2021.0448.R2.07022022 [doi] PST - ppublish SO - Sao Paulo Med J. 2022 Nov-Dec;140(6):767-774. doi: 10.1590/1516-3180.2021.0448.R2.07022022.